Thursday, October 05, 2017 9:31:55 PM
Ok so before you post any article you might want to do a little bit more DD. Try contacting the company see what has progressed.
Lets start with this, 5 phase 3 trials. Well each one has about 33% chance of being FDA approved. So that means at least one or even two make it.
1) Do they have the cash to get there? Well yes they do!
2) Do they have good management with FDA experience? Yes they do!
3) Do they have a broad pipeline meeting all time frames so far? Yes they do.
4) Is it possible to do a placebo trial on patients unaware they are even receiving treatment? Well thats pretty pointless. (FXS)
5) Do you know how much the phase 3 trials for FXS cost? Ok ill tell you about 5-10 million total. Best and cheapest runway for success!
6) How about there are no known treatments for spectrum disorders.
7) How about patented past 2030 with orphan drug designation giving almost a decade of exclusive marketing!
Ok now lets talk about O/A or osteoarthritis.
Met the most important secondary endpoints! Worked in men and not women. Restructure this with the FDA for phase 3 probably gonna have a solid update for this in December.
O/A largest market but also costly phase3 ($20+ million 300+ patients)
How about Zyn001? Well the only pro THC derived transdermal synthetic thats patent protected with all the same as above minus the results.
I tell you what my bet is here! any placebo test is an open and shut case
i believe that passing on this opportunity to buy the stock will be a large mistake people will look back and say wow i could have bought that for how much?! Its already traded at $25 before any results, has a low float enough cash till 2019 and is in the largest market space with the highest potential growth in the next 5 years!
Sorry for the rant here but i have alot to say and this article was pitiful! Longs will be winners here mark my words!
Thanks for the support of all my friends who held on through this rough ride, we should be rewarded handsomely!
-HT
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM